Korea Bio-Gen Co.Ltd Cash Flow Quality Index
Korea Bio-Gen Co.Ltd cash flow quality index. Korea Bio-Gen Co.Ltd (318000) has a Cash Flow Quality Index of 0.19x as of March 2026. Operating cash flow of ₩145.77 Million is below net income of ₩762.13 Million, suggesting accrual-heavy earnings not yet converted to cash. See financial agility of Korea Bio-Gen Co.Ltd to measure the company's free cash flow as a share of total liabilities.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Cash Flow Quality Index of Korea Bio-Gen Co.Ltd (2017–2025)
Cash flow quality index of Korea Bio-Gen Co.Ltd from 2017 to 2025. Historical Cash Flow Quality Index for Korea Bio-Gen Co.Ltd across 8 annual periods. Values consistently above 1.0x indicate high-quality earnings. Explore 318000 operating cash flow to total debt to assess how comfortably operating cash covers total debt obligations.
Korea Bio-Gen Co.Ltd Cash Flow Quality Index by Year (2017–2025)
Korea Bio-Gen Co.Ltd cash flow quality index by year from 2017 to 2025. Year-by-year earnings quality comparison for Korea Bio-Gen Co.Ltd. For the full cash flow conversion analysis, see 318000 cash flow conversion.
| Year | Quality Index | Operating CF (KRW) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 2.83x | ₩7.34 Billion | ₩2.59 Billion | ▲ +148.6% |
| 2024 | 1.14x | ₩4.29 Billion | ₩3.77 Billion | ▼ -44.9% |
| 2023 | 2.07x | ₩9.47 Billion | ₩4.58 Billion | ▲ +302.4% |
| 2022 | 0.51x | ₩1.67 Billion | ₩3.25 Billion | ▼ -33.6% |
| 2021 | 0.77x | ₩3.09 Billion | ₩4.00 Billion | ▼ -6.5% |
| 2020 | 0.83x | ₩2.58 Billion | ₩3.12 Billion | ▲ +6.6% |
| 2018 | 0.78x | ₩1.98 Billion | ₩2.56 Billion | ▲ +3.7% |
| 2017 | 0.75x | ₩1.38 Billion | ₩1.85 Billion | — |